Division of Genetics and Epidemiology, Institute of Cancer Research, Surrey, UK.
Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
Nat Genet. 2013 Oct;45(10):1221-1225. doi: 10.1038/ng.2733. Epub 2013 Aug 18.
To identify variants for multiple myeloma risk, we conducted a genome-wide association study with validation in additional series totaling 4,692 individuals with multiple myeloma (cases) and 10,990 controls. We identified four risk loci at 3q26.2 (rs10936599, P = 8.70 × 10(-14)), 6p21.33 (rs2285803, PSORS1C2, P = 9.67 × 10(-11)), 17p11.2 (rs4273077, TNFRSF13B, P = 7.67 × 10(-9)) and 22q13.1 (rs877529, CBX7, P = 7.63 × 10(-16)). These data provide further evidence for genetic susceptibility to this B-cell hematological malignancy, as well as insight into the biological basis of predisposition.
为了鉴定多发性骨髓瘤风险的变异,我们进行了一项全基因组关联研究,在总计 4692 名多发性骨髓瘤患者(病例)和 10990 名对照者的其他系列中进行了验证。我们在 3q26.2 处鉴定出四个风险位点(rs10936599,P=8.70×10(-14))、6p21.33(rs2285803,PSORS1C2,P=9.67×10(-11))、17p11.2(rs4273077,TNFRSF13B,P=7.67×10(-9))和 22q13.1(rs877529,CBX7,P=7.63×10(-16))。这些数据为这种 B 细胞血液恶性肿瘤的遗传易感性提供了进一步的证据,并深入了解了易感性的生物学基础。